Rethinking Clinical Trials

JULY 9, 2023

Tags #pctGR, @Collaboratory1 The post Grand Rounds June 16, 2023: BeatPain Utah: Partnering With Community Health Centers Within a Socio-Technical Framework (Julie Fritz, PT, PhD, FAPTA; Guilherme Del Fiol, MD, PhD) appeared first on Rethinking Clinical Trials.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

pharmaphorum

SEPTEMBER 15, 2020

The huge rise in the use of telemedicine services during lockdown has brought care directly to patients in their homes, while pharma’s communications with healthcare professionals (HCPs) has experienced a similar push to digital channels. Jeremy Richter, Tag. Build on the rapid responses to COVID-19.

Branding 130

Branding Marketing Pharma Companies Life Science 130

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 97

Regulation Marketing Sales Branding 97

Roots Analysis

JANUARY 28, 2024

Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.

Big Data 40

Big Data Medicine Marketing Clinical Trials 40

Delveinsight

JULY 22, 2020

Telemedicine, Artificial intelligence, Virtual reality, Augmented reality, Drones, Telehealthcare, 3D-printing, robotics, or nanotechnology are some of the emerging and existing technologies, which are expected to reshape the healthcare industry. The hospital inventory is equipped with tagged sensors. Medical Equipment Tracking.

Doctors 59

Doctors Doctor Marketing Production 59

XTalks

DECEMBER 21, 2022

The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive. Currently, CSL Behring’s one-dose Hemophilia B gene therapy Hemgenix holds the title at $3.5 million for a single infusion.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52